# ENGS (Energys Group Limited) - SEC EDGAR Financial Statements

> Energys Group Limited reported £10.47M in revenue and net income of £287K for the fiscal year ended June 30, 2026 (up 52.0% year over year), with a 31.9% gross margin and a -12.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/ENGS
- Markdown: https://convexityos.com/fundamentals/ENGS.md
- SEC CIK: 0001971828
- Reporting currency: GBP
- Latest filing period: June 30, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001971828&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | £10.47M | +52.0% YoY |
| Operating Income | FY 2026 | -£1.29M | -12.3% margin |
| Net Income | FY 2026 | £287K | 2.7% net margin |
| Diluted EPS | FY 2026 | £0.01 | Split-adjusted |
| Free Cash Flow | FY 2026 | -£876K | -8.4% FCF margin |
| Cash & ST Investments | Jun 30, 2026 | £6.09M | Total debt: £4.38M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| **Revenue** | £10.47M | £6.89M | £9.60M | £6.01M |
| Cost of Revenue | £7.13M | £5.48M | £7.46M | £4.92M |
| **Gross Profit** | £3.34M | £1.41M | £2.14M | £1.08M |
| Research & Development | £116K | £129K | £261K | £257K |
| Selling, General & Admin | -- | £1.26M | £924K | £1.11M |
| Total Operating Expenses | £4.63M | £3.15M | £2.38M | £2.64M |
| **Operating Income** | -£1.29M | -£1.74M | -£233K | -£1.56M |
| **EBITDA** | -£1.16M | -£1.59M | -£97K | -£1.42M |
| Income Before Tax | £287K | -£2.08M | -£1.11M | -£2.11M |
| Income Tax Expense | -- | -- | £2.5K | £177K |
| **Net Income** | £287K | -£2.08M | -£1.11M | -£2.28M |
| Basic EPS | £0.01 | -£0.17 | -£0.09 | -£0.19 |
| **Diluted EPS** | £0.01 | -£0.17 | -£0.09 | -£0.19 |
| Basic Shares Outstanding | 21.4M | 12.6M | 12.0M | 12.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | £260K | £193K | £261K |
| Short-Term Investments | £5.83M | -- | -- |
| **Cash & Short-Term Investments** | £6.09M | £193K | £261K |
| Inventory | £1.13M | £1.08M | £1.09M |
| **Total Current Assets** | £13.14M | £7.46M | £5.36M |
| Property, Plant & Equipment, Net | £2.68M | £2.74M | £3.13M |
| **Total Non-Current Assets** | £2.98M | £3.02M | £3.32M |
| **Total Assets** | £16.12M | £10.48M | £8.68M |
| Accounts Payable | £1.02M | £975K | £1.14M |
| Deferred Revenue (Current) | £131K | £619K | £158K |
| **Total Current Liabilities** | £7.39M | £8.85M | £10.43M |
| Long-Term Debt | £4.18M | £6.12M | £7.90M |
| **Total Non-Current Liabilities** | £112K | £139K | £248K |
| **Total Liabilities** | £7.50M | £8.99M | £10.68M |
| **Total Debt (incl. Leases)** | £4.38M | £6.39M | £8.06M |
| Common Stock | -- | £1.2K | £987 |
| Retained Earnings | -£9.05M | -£9.34M | -£7.26M |
| Accumulated Other Comp. Income | £67K | -£64K | £153K |
| **Total Stockholders' Equity** | £8.62M | £1.49M | -£2.00M |
| Total Equity | £8.62M | £1.49M | -£2.00M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Jun 2025 | Jun 2024 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | £260K | £193K | £261K |
| Short-Term Investments | £5.83M | -- | -- |
| **Cash & Short-Term Investments** | £6.09M | £193K | £261K |
| Inventory | £1.13M | £1.08M | £1.09M |
| **Total Current Assets** | £13.14M | £7.46M | £5.36M |
| Property, Plant & Equipment, Net | £2.68M | £2.74M | £3.13M |
| **Total Non-Current Assets** | £2.98M | £3.02M | £3.32M |
| **Total Assets** | £16.12M | £10.48M | £8.68M |
| Accounts Payable | £1.02M | £975K | £1.14M |
| Deferred Revenue (Current) | £131K | £619K | £158K |
| **Total Current Liabilities** | £7.39M | £8.85M | £10.43M |
| Long-Term Debt | £4.18M | £6.12M | £7.90M |
| **Total Non-Current Liabilities** | £112K | £139K | £248K |
| **Total Liabilities** | £7.50M | £8.99M | £10.68M |
| **Total Debt (incl. Leases)** | £4.38M | £6.39M | £8.06M |
| Common Stock | -- | £1.2K | £987 |
| Retained Earnings | -£9.05M | -£9.34M | -£7.26M |
| Accumulated Other Comp. Income | £67K | -£64K | £153K |
| **Total Stockholders' Equity** | £8.62M | £1.49M | -£2.00M |
| Total Equity | £8.62M | £1.49M | -£2.00M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| Net Income | £287K | -£2.08M | -£1.11M | -£2.28M |
| Depreciation & Amortization | £127K | £144K | £136K | £141K |
| Change in Inventory | -£67K | -£43K | £734K | £825K |
| Change in Payables | £41K | -£145K | £283K | -£59K |
| **Operating Cash Flow** | -£868K | -£500K | -£1.43M | -£630K |
| Capital Expenditure | -£7.7K | -£8.1K | -£32K | -£1.2K |
| **Free Cash Flow** | -£876K | -£508K | -£1.47M | -£631K |
| **Investing Cash Flow** | -£3.85M | -£3.97M | £134K | -£1.2K |
| **Financing Cash Flow** | £4.79M | £4.41M | £1.34M | £836K |
| **Net Change in Cash** | £67K | -£67K | £40K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 31.9% | 20.4% | 22.3% | 18.1% |
| **Operating Margin** | -12.3% | -25.2% | -2.4% | -25.9% |
| **Net Profit Margin** | 2.7% | -30.1% | -11.6% | -38.0% |
| Return on Equity (ROE) | 3.3% | -139.3% | -- | -- |
| Return on Assets (ROA) | 1.8% | -19.8% | -12.8% | -- |
| Current Ratio | 1.78x | 0.84x | 0.51x | -- |
| Quick Ratio | 1.63x | 0.72x | 0.41x | -- |
| Debt to Equity | 0.51x | 4.29x | -- | -- |
| **Revenue Growth (YoY)** | +52.0% | -28.2% | +59.9% | -- |
| Gross Profit Growth (YoY) | +137.0% | -34.2% | +97.5% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
